Thrombotic microangiopathies - availability of diagnostic methods and treatment options in the Czech Republic in 2021: results of a syndicated survey among clinical haematologists
Abstract
From September to October 2021, at the request of the Centre for Thrombotic Microangiopathies Ostrava (C4TMO) and the Czech Group for Thrombotic Microangiopathies (CS4TMA), an online survey prepared by IQVIA based on CS4TMA data was conducted among clinical haematologists to verify the awareness of clinical haematologists about the rules and availability of care for patients with thrombotic microangiopathies. The professional basis for the development of the questionnaire was the formulation of good clinical practice guidelines for the care of patients with thrombotic thrombocytopenic purpura.
A total of 49 interviews were conducted. The results of the survey indicate very good clinical practice for the care of patients with acute thrombotic microangiopathy at the respondents' institutions.
However, the spectrum of departments that participated in the survey does not correspond to the actual spectrum of haematology departments in the Czech Republic. In particular, data from small outpatient clinics within type II hospitals or outside hospitals are missing.